Phexxi FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 27, 2021.
FDA Approved: Yes (First approved May 22, 2020)
Brand name: Phexxi
Generic name: lactic acid, citric acid and potassium bitartrate
Dosage form: Vaginal Gel
Previous Name: Amphora
Company: Evofem, Inc.
Treatment for: Birth Control
Phexxi (lactic acid, citric acid and potassium bitartrate) is a non-hormonal vaginal gel indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
- How well does Phexxi work?
Your chance of getting pregnant depends on how well you follow the directions for using Phexxi. The better you follow the directions, the less chance you have of getting pregnant. It is very important that you follow the directions carefully each time you have vaginal sex. Phexxi is not effective for the prevention of pregnancy when administered after intercourse.
- Phexxi is administered by inserting one pre-filled single-dose applicator into the vagina immediately before (or up to one hour before) each episode of vaginal intercourse.
- Common adverse reactions (≥2%) include vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal mycotic infection, urinary tract infection, vulvovaginal discomfort, bacterial vaginosis, vaginal discharge, genital discomfort, dysuria, and vulvovaginal pain.
Development timeline for Phexxi
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.